1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

MesoTV: Anna Nowak, MD, PhD, of the University of Western Australia

mesothelioma immunotherapy

Anna Nowak, MD, PhD, speaks about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19’s effects on mesothelioma in treatment in Australia.

Dr. Nowak is a medical oncologist at Sir Charles Gairdner Hospital (SCGH) and professor within the School of Medicine at The University of Western Australia. She is also a former member of the Foundation’s Science Advisory Board.

Watch MesoTV

This MesoTV interview was made possible by the support of sponsors who have stepped up during this difficult time to ensure that we can continue serving the mesothelioma community. Please take note of them at the beginning of the video: Novocure; Belluck & Fox, LLP; University of Pittsburgh Medical Center (UPMC); Vogelzang Law; and Merrill Lynch.

Get notified when our next video is published by clicking the red “Subscribe” button below.

MesoTV is the Mesothelioma Applied Research Foundation’s recorded video series covering pertinent conversations impacting the mesothelioma community. You can learn more at curemeso.org/mesotv.

Also...

In Other News

Clinical Trials

Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different

Read More »

Peritoneal Surgery/HIPEC

Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC).  This session

Read More »

Share:

Facebook
Twitter
LinkedIn